216 related articles for article (PubMed ID: 9810319)
41. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous superficial hyperthermia and external radiotherapy: report of thermal dosimetry and tolerance to treatment.
Myerson RJ; Straube WL; Moros EG; Emami BN; Lee HK; Perez CA; Taylor ME
Int J Hyperthermia; 1999; 15(4):251-66. PubMed ID: 10458566
[TBL] [Abstract][Full Text] [Related]
43. Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancer.
Crezee J; van Leeuwen CM; Oei AL; van Heerden LE; Bel A; Stalpers LJ; Ghadjar P; Franken NA; Kok HP
Radiat Oncol; 2016 Feb; 11():14. PubMed ID: 26831185
[TBL] [Abstract][Full Text] [Related]
44. [Large volume stage I and II epidermoid carcinoma of the uterine cervix treated with primary radiotherapy and surgery].
Touboul E; Lefranc JP; Belkacémi Y; Rogel A; Deluen F; Blondon J; Housset M
Contracept Fertil Sex; 1998 Sep; 26(9):674-85. PubMed ID: 9823696
[TBL] [Abstract][Full Text] [Related]
45. Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate.
Anscher MS; Samulski TV; Dodge R; Prosnitz LR; Dewhirst MW
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1059-65. PubMed ID: 9169813
[TBL] [Abstract][Full Text] [Related]
46. Local hyperthermia of N2/N3 cervical lymph node metastases: correlationof technical/thermal parameters and response.
Wust P; Stahl H; Dieckmann K; Scheller S; Löffel J; Riess H; Bier J; Jahnke V; Felix R
Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):635-46. PubMed ID: 8621288
[TBL] [Abstract][Full Text] [Related]
47. Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results.
Van Vulpen M; De Leeuw AA; Raaymakers BW; Van Moorselaar RJ; Hofman P; Lagendijk JJ; Battermann JJ
BJU Int; 2004 Jan; 93(1):36-41. PubMed ID: 14678364
[TBL] [Abstract][Full Text] [Related]
48. Six fractions per week of external beam radiotherapy and high-dose-rate brachytherapy for carcinoma of the uterine cervix: A phase I/II study.
Yoon SM; Huh SJ; Park W; Lee JE; Park YJ; Nam HR; Lim DH; Ahn YC
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1508-13. PubMed ID: 16793216
[TBL] [Abstract][Full Text] [Related]
49. [Neoadjuvant chemotherapy of stage IIb or III cancers of the uterine cervix. Long-term results of a multicenter randomized trial of 151 patients].
Chauvergne J; Lhommé C; Rohart J; Héron JF; Ayme Y; Goupil A; Fargeot P; David M
Bull Cancer; 1993 Dec; 80(12):1069-79. PubMed ID: 8081045
[TBL] [Abstract][Full Text] [Related]
50. High dose rate cobalt-60 afterloading intracavitary therapy of uterine cervical carcinomas in Srinagarind hospital - analysis of complications.
Pesee M; Krusun S; Padoongcharoen P
Asian Pac J Cancer Prev; 2010; 11(2):491-4. PubMed ID: 20843138
[TBL] [Abstract][Full Text] [Related]
51. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
Micheletti E; La Face B; Bianchi E; Cagna E; Sartori E
Radiol Med; 1996 May; 91(5):628-34. PubMed ID: 8693131
[TBL] [Abstract][Full Text] [Related]
52. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
Rogers CL; Freel JH; Speiser BL
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):95-100. PubMed ID: 9989519
[TBL] [Abstract][Full Text] [Related]
53. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
54. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
[TBL] [Abstract][Full Text] [Related]
55. Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study.
Macchia G; Cilla S; Deodato F; Legge F; Di Stefano A; Chiantera V; Scambia G; Valentini V; Morganti AG; Ferrandina G
Br J Radiol; 2015; 88(1055):20150385. PubMed ID: 26388108
[TBL] [Abstract][Full Text] [Related]
56. Hyperthermia and radiotherapy for inoperable squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site.
Amichetti M; Romano M; Cristoforetti L; Valdagni R
Int J Hyperthermia; 2000; 16(1):85-93. PubMed ID: 10669319
[TBL] [Abstract][Full Text] [Related]
57. HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy--a phase III study.
Zolciak-Siwinska A; Piotrkowicz N; Jonska-Gmyrek J; Nicke-Psikuta M; Michalski W; Kawczyńska M; Bijok M; Bujko K
Radiother Oncol; 2013 Nov; 109(2):194-9. PubMed ID: 23684588
[TBL] [Abstract][Full Text] [Related]
58. Uterosacral space involvement in locally advanced carcinoma of the uterine cervix.
Chao KS; Williamson JF; Grigsby PW; Perez CA
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):397-403. PubMed ID: 9457827
[TBL] [Abstract][Full Text] [Related]
59. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
60. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
